A Life Sciences Canada Profile

Antibe is a commercial-stage pharmaceutical company focused on pain, inflammation and regenerative medicine. Antibe's lead drug, ATB-346, targets the global need for a safer non-steroidal anti-inflammatory drug (“NSAID”) for treating chronic pain and inflammation with non-addictive medication. Antibe's subsidiary, Citagenix Inc., is a leader in Canada in the sales and marketing of tissue regenerative products servicing the orthopaedic and dental marketplaces, and is active internationally via distributors.